AUTOLUS THERAPEUTICS PLC's ticker is AUTL and the CUSIP is 05280R100. A total of 69 filers reported holding AUTOLUS THERAPEUTICS PLC in Q2 2023. The put-call ratio across all filers is 0.06 and the average weighting 1.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $1,568,408 | – | 658,995 | – | 0.58% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Syncona Portfolio Ltd | 7,346,829 | $15,723,000 | 27.32% |
| TFG Asset Management GP Ltd | 3,039,381 | $6,504,000 | 0.78% |
| Nantahala Capital Management | 5,215,788 | $11,162,000 | 0.72% |
| Frazier Life Sciences Management, L.P. | 3,746,857 | $8,018,000 | 0.62% |
| HARBOR CAPITAL ADVISORS, INC. | 148,454 | $318,000 | 0.29% |
| DAFNA Capital Management LLC | 496,150 | $1,062,000 | 0.29% |
| Blackstone Inc. | 17,985,611 | $38,489 | 0.14% |
| Ikarian Capital, LLC | 260,087 | $556,000 | 0.11% |
| MYDA Advisors LLC | 100,000 | $214,000 | 0.10% |
| Privium Fund Management B.V. | 113,528 | $253,000 | 0.09% |